The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Genome-based prediction of common diseases: advances and prospects
Open accessAbstract
Common diseases such as type 2 diabetes and coronary heart disease result from a complex interplay of genetic and environmental factors. Recent developments in genomics research have boosted progress in the discovery of susceptibility genes and fueled expectations about opportunities of genetic profiling for personalizing medicine. Personalized medicine requires a test that fairly accurately predicts disease risk, particularly when interventions are invasive, expensive or have major side effects. Recent studies on the prediction of common diseases based on multiple genetic variants alone or in addition to traditional disease risk factors showed limited predictive value so far, but all have investigated only a limited number of susceptibility variants. New gene discoveries from genome-wide association studies will certainly further improve the prediction of common diseases, but the question is whether this improvement is sufficient to enable personalized medicine. In this paper, we argue that new gene discoveries may not evidently improve the prediction of common diseases to a degree that it will change the management of individuals at increased risk. Substantial improvements may only be expected if we manage to understand the complete causal mechanisms of common diseases to a similar extent as we understand those of monogenic disorders. Genomics research will contribute to this understanding, but it is likely that the complexity of complex diseases may ultimately limit the opportunities for accurate prediction of disease in asymptomatic individuals as unraveling their complete causal pathways may be impossible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1989) · PubMed · Cited by 3,139
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 2,924
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523 · cited 1×
“For instance, genes associated with cardiovascular disease may also be involved in intermediate outcomes as dyslipidemia or hypertension or even smoking (26,28).”
BackgroundLifetime risk for diabetes mellitus in the United States
Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515
The Rotterdam Study: objectives and design update
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,395
Self-citationThe International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN), Harley, J. B., Alarcón-Riquelme, M. E., Criswell, L. A., Jacob, C. O., Kimberly, R. P., Moser, K. L., Tsao, B. P., Vyse, T. J., & Langefeld, C. D. (2008) · Nature Genetics · doi:10.1038/ng.81 · Cited by 1,309
Causation and Causal Inference in Epidemiology
Rothman, K. J., & Greenland, S. (2005) · American Journal of Public Health · doi:10.2105/ajph.2004.059204 · Cited by 1,259
Riboli, E. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.suppl_1.s6 · Cited by 945
A HapMap harvest of insights into the genetics of common disease
Manolio, T. A., Brooks, L. D., & Collins, F. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34772 · Cited by 889 · cited 1×
“Genome-wide association studies are rapidly unraveling the role of genetic factors in the pathogeneses of common diseases (1).”
BackgroundPrediction of individual genetic risk to disease from genome-wide association studies
Wray, N. R., Goddard, M. E., & Visscher, P. M. (2007) · Genome Research · doi:10.1101/gr.6665407 · Cited by 725
Khoury, M. J., Gwinn, M., Yoon, P. W., Dowling, N., Moore, C. A., & Bradley, L. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31815699d0 · Cited by 705
Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
Kathiresan, S., Melander, O., Anevski, D., Guiducci, C., Burtt, N. P., Roos, C., Hirschhorn, J. N., Berglund, G., Hedblad, B., Groop, L., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706728 · Cited by 696
Cumulative Association of Five Genetic Variants with Prostate Cancer
Zheng, S. L., Sun, J., Wiklund, F., Smith, S., Stattin, P., Li, G., Adami, H.-O., Hsu, F.-C., Zhu, Y., Bälter, K., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa075819 · Cited by 631
Polygenes, Risk Prediction, and Targeted Prevention of Breast Cancer
Pharoah, P. D. P., Antoniou, A. C., Easton, D. F., & Ponder, B. A. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0708739 · Cited by 618
Maller, J., George, S., Purcell, S., Fagerness, J., Altshuler, D., Daly, M. J., & Seddon, J. M. (2006) · Nature Genetics · doi:10.1038/ng1873 · Cited by 599 · cited 1×
“While the predictive value in these two studies may have been overestimated because they were performed in hyperselected populations not representative for clinical practice, comparing individuals with end-stage AMD with those without eye abnormalities (8,18) and individuals with hypertriglyceridemia with normolipidem…”
BackgroundThe EPIC Project: Rationale and study design
Ríboli, E., & Kaaks, R. (1997) · International Journal of Epidemiology · Cited by 487
Will Genetics Revolutionize Medicine?
Holtzman, N. A., & Marteau, T. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430213 · Cited by 408
Lango, H., the U.K. Type 2 Diabetes Genetics Consortium, Palmer, C. N. A., Morris, A. D., Zeggini, E., Hattersley, A. T., McCarthy, M. I., Frayling, T. M., & Weedon, M. N. (2008) · Diabetes · doi:10.2337/db08-0504 · Cited by 294
Morrison, A. C., Bare, L. A., Chambless, L. E., Ellis, S. G., Malloy, M., Kane, J. P., Pankow, J. S., Devlin, J. J., Willerson, J. T., & Boerwinkle, E. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm060 · Cited by 282
Predicting Type 2 Diabetes Based on Polymorphisms From Genome-Wide Association Studies
van Hoek, M., Dehghan, A., Witteman, J. C. M., van Duijn, C. M., Uitterlinden, A. G., Oostra, B. A., Hofman, A., Sijbrands, E. J. G., & Janssens, A. C. J. W. (2008) · Diabetes · doi:10.2337/db08-0425 · Cited by 280
Self-citationCombining Information from Common Type 2 Diabetes Risk Polymorphisms Improves Disease Prediction
Weedon, M. N., McCarthy, M. I., Hitman, G., Walker, M., Groves, C. J., Zeggini, E., Rayner, N. W., Shields, B., Owen, K. R., Hattersley, A. T., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030374 · Cited by 268
The Generation R Study Biobank: a resource for epidemiological studies in children and their parents
Jaddoe, V. W. V., Bakker, R., van Duijn, C. M., van der Heijden, A. J., Lindemans, J., Mackenbach, J. P., Moll, H. A., Steegers, E. A. P., Tiemeier, H., Uitterlinden, A. G., et al. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9209-z · Cited by 250
Self-citationPredictive testing for complex diseases using multiple genes: Fact or fiction?
Janssens, A. C. J. W., Aulchenko, Y. S., Elefante, S., Borsboom, G. J. J. M., Steyerberg, E. W., & van Duijn, C. M. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000229689.18263.f4 · Cited by 232
Self-citationHow many genes underlie the occurrence of common complex diseases in the population?
Yang, Q., Khoury, M. J., Friedman, J., Little, J., & Flanders, W. D. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi130 · Cited by 184
Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study
Vaxillaire, M., Veslot, J., Dina, C., Cavalcanti-Proença, C., Cauchi, S., Charpentier, G., Tichet, J., Fumeron, F., Marre, M., Meyre, D., et al. (2007) · Diabetes · doi:10.2337/db07-0615 · Cited by 171
Misconceptions about the use of genetic tests in populations
Vineis, P., Schulte, P. A., & McMichael, A. J. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04136-2 · Cited by 170
Genomic profiling to promote a healthy lifestyle: not ready for prime time
Haga, S. B., Khoury, M. J., & Burke, W. (2003) · Nature Genetics · doi:10.1038/ng0803-347 · Cited by 167
Improving the Prediction of Complex Diseases by Testing for Multiple Disease-Susceptibility Genes
Yang, Q., Khoury, M. J., Botto, L. D., Friedman, J. M., & Flanders, W. D. (2003) · The American Journal of Human Genetics · doi:10.1086/367923 · Cited by 156
Janssens, A. C. J. W., Moonesinghe, R., Yang, Q., Steyerberg, E. W., van Duijn, C. M., & Khoury, M. J. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31812eece0 · Cited by 154
Self-citationRealizing the Promise of Genomics in Biomedical Research
Guttmacher, A. E., & Collins, F. S. (2005) · JAMA · doi:10.1001/jama.294.11.1399 · Cited by 149
Genetic Prediction of Future Type 2 Diabetes
Lyssenko, V., Almgren, P., Anevski, D., Orho‐Melander, M., Sjögren, M., Saloranta, C., Tuomi, T., Groop, L., & the Botnia Study Group (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020345 · Cited by 146
Polygenic determinants of severe hypertriglyceridemia
Wang, J., Ban, M. R., Zou, G., Cao, H., Lin, T., Kennedy, B. A., Anand, S., Yusuf, S., Huff, M. W., Pollex, R. L., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn188 · Cited by 138
Podgoreanu, M. V., White, W., Morris, R. W., Mathew, J. P., Stafford‐Smith, M., Welsby, I. J., Grocott, H. P., Milano, C. A., Newman, M. F., Schwinn, D. A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.001032 · Cited by 136
The impact of genetics and genomics on public health
Brand, A. M., Brand, H., & den Bäumen, T. S. I. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201942 · Cited by 103
Humphries, S. E., Cooper, J. A., Talmud, P. J., & Miller, G. J. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.074591 · Cited by 93
Does Genetic Testing Really Improve the Prediction of Future Type 2 Diabetes?
Janssens, A. C. J. W., GWINN, M. L., Subramonia-Iyer, S., & Khoury, M. J. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030114 · Cited by 34
Self-citationJanssens, A. C. J. W., & Khoury, M. J. (2006) · Italian Journal of Public Health · doi:10.2427/5915 · Cited by 23
Self-citationSilva, N. M. G. D., Steele, A. M., Shields, B. M., Knight, B., Parnell, K. S., Weedon, M. N., Hattersley, A. T., & Frayling, T. M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02253.x · Cited by 22
Cited by
Benefits and limitations of genome-wide association studies
Tam, V., Patel, N., Turcotte, M., Bossé, Y., Paré, G., & Meyre, D. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0127-1 · Cited by 2,092
Genomewide Association Studies and Assessment of the Risk of Disease
Manolio, T. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0905980 · Cited by 1,512
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
Genomics, type 2 diabetes, and obesity
McCarthy, M. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0906948 · Cited by 938
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
the ENGAGE Consortium (2009) · Nature Genetics · doi:10.1038/ng.269 · Cited by 854
Metadata
- Authors
- Janssens, A. C. J. W., & van Duijn, C. M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-15
- Volume
- 17
- Issue
- R2
- Pages
- R166-R173
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2143142289
- Cited by
- 314
- References
- 39
- FWCI
- 21.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.